# Frontdoor, Inc.: financial statements, quarterly

FTDR · Nasdaq · CIK 1727263 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ftdr.md) · [Financials](/companies/ftdr/financials.md) · [Filings](/companies/ftdr/filings.md) · [Insiders](/companies/ftdr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ftdr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [524](/filings/0000950170-24-120674.md) | [366 d](/filings/0001193125-26-076548.md) | [378](/filings/0000950170-25-061815.md) | [542](/filings/0000950170-25-103008.md) | [540](/filings/0001193125-25-267020.md) | [382 d](/filings/0001193125-26-076548.md) | [426](/filings/0001193125-26-197175.md) | [617](/filings/0001727263-26-000014.md) | [618](/filings/0001193125-25-267020.md) | [433 d](/filings/0001193125-26-076548.md) | [451](/filings/0001193125-26-197175.md) | [645](/filings/0001727263-26-000014.md) |
| Cost of revenue | $m | [256](/filings/0000950170-24-120674.md) | [189 d](/filings/0001193125-26-076548.md) | [184](/filings/0000950170-25-061815.md) | [237](/filings/0000950170-25-103008.md) | [235](/filings/0001193125-25-267020.md) | [197 d](/filings/0001193125-26-076548.md) | [191](/filings/0001193125-26-197175.md) | [261](/filings/0001727263-26-000014.md) | [264](/filings/0001193125-25-267020.md) | [220 d](/filings/0001193125-26-076548.md) | [203](/filings/0001193125-26-197175.md) | [267](/filings/0001727263-26-000014.md) |
| Gross profit | $m | [268](/filings/0000950170-24-120674.md) | [177 d](/filings/0001193125-26-076548.md) | [195](/filings/0000950170-25-061815.md) | [306](/filings/0000950170-25-103008.md) | [306](/filings/0001193125-25-267020.md) | [185 d](/filings/0001193125-26-076548.md) | [235](/filings/0001193125-26-197175.md) | [356](/filings/0001727263-26-000014.md) | [353](/filings/0001193125-25-267020.md) | [213 d](/filings/0001193125-26-076548.md) | [248](/filings/0001193125-26-197175.md) | [378](/filings/0001727263-26-000014.md) |
| Selling, general and administrative | $m | [152](/filings/0000950170-24-120674.md) | [142 d](/filings/0001193125-26-076548.md) | [135](/filings/0000950170-25-061815.md) | [167](/filings/0000950170-25-103008.md) | [154](/filings/0001193125-25-267020.md) | [156 d](/filings/0001193125-26-076548.md) | [151](/filings/0001193125-26-197175.md) | [172](/filings/0001727263-26-000014.md) | [174](/filings/0001193125-25-267020.md) | [171 d](/filings/0001193125-26-076548.md) | [162](/filings/0001193125-26-197175.md) | [176](/filings/0001727263-26-000014.md) |
| Interest expense | $m | [10.0](/filings/0000950170-24-120674.md) | [10.0 d](/filings/0001193125-26-076548.md) | [10.0](/filings/0000950170-25-061815.md) | [10.0](/filings/0000950170-25-103008.md) | [10.0](/filings/0001193125-25-267020.md) | [11.0 d](/filings/0001193125-26-076548.md) | [19.0](/filings/0001193125-26-197175.md) | [20.0](/filings/0001727263-26-000014.md) | [20.0](/filings/0001193125-25-267020.md) | [20.0 d](/filings/0001193125-26-076548.md) | [19.0](/filings/0001193125-26-197175.md) | [19.0](/filings/0001727263-26-000014.md) |
| Income tax | $m | [24.0](/filings/0000950170-24-120674.md) | [3.0 d](/filings/0001193125-26-076548.md) | [11.0](/filings/0000950170-25-061815.md) | [32.0](/filings/0000950170-25-103008.md) | [34.0](/filings/0001193125-25-267020.md) | [(3.0) d](/filings/0001193125-26-076548.md) | [11.0](/filings/0001193125-26-197175.md) | [36.0](/filings/0001727263-26-000014.md) | [37.0](/filings/0001193125-25-267020.md) | [1.0 d](/filings/0001193125-26-076548.md) | [10.0](/filings/0001193125-26-197175.md) | [41.0](/filings/0001727263-26-000014.md) |
| Net income | $m | [71.0](/filings/0000950170-24-120674.md) | [8.0 d](/filings/0001193125-26-076548.md) | [34.0](/filings/0000950170-25-061815.md) | [92.0](/filings/0000950170-25-103008.md) | [100](/filings/0001193125-25-267020.md) | [9.0 d](/filings/0001193125-26-076548.md) | [37.0](/filings/0001193125-26-197175.md) | [111](/filings/0001727263-26-000014.md) | [106](/filings/0001193125-25-267020.md) | [2.0 d](/filings/0001193125-26-076548.md) | [41.0](/filings/0001193125-26-197175.md) | [125](/filings/0001727263-26-000014.md) |
| Diluted EPS | $ per share | [0.89](/filings/0000950170-24-120674.md) | not reported | [0.43](/filings/0000950170-25-061815.md) | [1.18](/filings/0000950170-25-103008.md) | [1.30](/filings/0001193125-25-267020.md) | not reported | [0.49](/filings/0001193125-26-197175.md) | [1.48](/filings/0001727263-26-000014.md) | [1.42](/filings/0001193125-25-267020.md) | not reported | [0.57](/filings/0001193125-26-197175.md) | [1.76](/filings/0001727263-26-000014.md) |
| Basic EPS | $ per share | [0.89](/filings/0000950170-24-120674.md) | not reported | [0.43](/filings/0000950170-25-061815.md) | [1.18](/filings/0000950170-25-103008.md) | [1.32](/filings/0001193125-25-267020.md) | not reported | [0.50](/filings/0001193125-26-197175.md) | [1.51](/filings/0001727263-26-000014.md) | [1.45](/filings/0001193125-25-267020.md) | not reported | [0.58](/filings/0001193125-26-197175.md) | [1.80](/filings/0001727263-26-000014.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [320](/filings/0001562762-23-000390.md) | [325](/filings/0000950170-25-028375.md) | [378](/filings/0000950170-24-052064.md) | [419](/filings/0000950170-24-089247.md) | [375](/filings/0000950170-24-120674.md) | [421](/filings/0001193125-26-076548.md) | [506](/filings/0000950170-25-061815.md) | [562](/filings/0000950170-25-103008.md) | [563](/filings/0001193125-25-267020.md) | [566](/filings/0001727263-26-000014.md) | [603](/filings/0001193125-26-197175.md) | [627](/filings/0001727263-26-000014.md) |
| Current assets | $m | [429](/filings/0001562762-23-000390.md) | [363](/filings/0000950170-25-028375.md) | [412](/filings/0000950170-24-052064.md) | [463](/filings/0000950170-24-089247.md) | [484](/filings/0000950170-24-120674.md) | [488](/filings/0001193125-26-076548.md) | [554](/filings/0000950170-25-061815.md) | [620](/filings/0000950170-25-103008.md) | [695](/filings/0001193125-25-267020.md) | [624](/filings/0001727263-26-000014.md) | [661](/filings/0001193125-26-197175.md) | [692](/filings/0001727263-26-000014.md) |
| Total assets | $m | [1,168](/filings/0001562762-23-000390.md) | [1,089](/filings/0001193125-26-076548.md) | [2,107](/filings/0000950170-25-061815.md) | [1,200](/filings/0000950170-24-089247.md) | [1,217](/filings/0000950170-24-120674.md) | [2,107](/filings/0001193125-26-076548.md) | [2,121](/filings/0000950170-25-061815.md) | [2,172](/filings/0000950170-25-103008.md) | [2,227](/filings/0001193125-25-267020.md) | [2,142](/filings/0001727263-26-000014.md) | [2,164](/filings/0001193125-26-197175.md) | [2,186](/filings/0001727263-26-000014.md) |
| Current liabilities | $m | [364](/filings/0001562762-23-000390.md) | [331](/filings/0000950170-25-028375.md) | [360](/filings/0000950170-24-052064.md) | [365](/filings/0000950170-24-089247.md) | [341](/filings/0000950170-24-120674.md) | [369](/filings/0001193125-26-076548.md) | [414](/filings/0000950170-25-061815.md) | [416](/filings/0000950170-25-103008.md) | [401](/filings/0001193125-25-267020.md) | [402](/filings/0001727263-26-000014.md) | [451](/filings/0001193125-26-197175.md) | [435](/filings/0001727263-26-000014.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | [597](/filings/0001562762-23-000390.md) | [593](/filings/0000950170-25-028375.md) | [589](/filings/0000950170-24-052064.md) | [586](/filings/0000950170-24-089247.md) | [582](/filings/0000950170-24-120674.md) | [1,199](/filings/0001193125-26-076548.md) | [1,193](/filings/0000950170-25-061815.md) | [1,186](/filings/0000950170-25-103008.md) | [1,180](/filings/0001193125-25-267020.md) | [1,173](/filings/0001727263-26-000014.md) | [1,167](/filings/0001193125-26-197175.md) | [1,160](/filings/0001727263-26-000014.md) |
| Shareholders' equity | $m | [171](/filings/0000950170-24-120674.md) | [136](/filings/0001193125-26-076548.md) | [162](/filings/0000950170-25-061815.md) | [214](/filings/0000950170-25-103008.md) | [261](/filings/0001193125-25-267020.md) | [239](/filings/0001193125-26-076548.md) | [198](/filings/0001193125-26-197175.md) | [254](/filings/0001727263-26-000014.md) | [316](/filings/0001193125-25-267020.md) | [242](/filings/0001727263-26-000014.md) | [230](/filings/0001193125-26-197175.md) | [284](/filings/0001727263-26-000014.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [27.0 d](/filings/0000950170-24-120674.md) | [63.0 d](/filings/0001193125-26-076548.md) | [84.0](/filings/0000950170-25-061815.md) | [103 d](/filings/0000950170-25-103008.md) | [25.0 d](/filings/0001193125-25-267020.md) | [58.0 d](/filings/0001193125-26-076548.md) | [124](/filings/0001193125-26-197175.md) | [127 d](/filings/0001727263-26-000014.md) | [64.0 d](/filings/0001193125-25-267020.md) | [101 d](/filings/0001193125-26-076548.md) | [119](/filings/0001193125-26-197175.md) | [126 d](/filings/0001727263-26-000014.md) |
| Capital expenditure | $m | [8.0 d](/filings/0000950170-24-120674.md) | [9.0 d](/filings/0001193125-26-076548.md) | [10.0](/filings/0000950170-25-061815.md) | [12.0 d](/filings/0000950170-25-103008.md) | [9.0 d](/filings/0001193125-25-267020.md) | [8.0 d](/filings/0001193125-26-076548.md) | [7.0](/filings/0001193125-26-197175.md) | [7.0 d](/filings/0001727263-26-000014.md) | [6.0 d](/filings/0001193125-25-267020.md) | [6.0 d](/filings/0001193125-26-076548.md) | [6.0](/filings/0001193125-26-197175.md) | [6.0 d](/filings/0001727263-26-000014.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [42.0 d](/filings/0000950170-24-120674.md) | [45.0 d](/filings/0001193125-26-076548.md) | [13.0](/filings/0000950170-25-061815.md) | [45.0 d](/filings/0000950170-25-103008.md) | [62.0 d](/filings/0001193125-25-267020.md) | [41.0 d](/filings/0001193125-26-076548.md) | [71.0](/filings/0001193125-26-197175.md) | [64.0 d](/filings/0001727263-26-000014.md) | [60.0 d](/filings/0001193125-25-267020.md) | [88.0 d](/filings/0001193125-26-076548.md) | [61.0](/filings/0001193125-26-197175.md) | [91.0 d](/filings/0001727263-26-000014.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [81.6](/filings/0001562762-23-000390.md) | [81.9](/filings/0000950170-24-052064.md) | [81.8](/filings/0000950170-24-089247.md) | [80.6](/filings/0000950170-24-120674.md) | [79.0](/filings/0000950170-25-061815.md) | [78.1](/filings/0000950170-25-103008.md) | [77.1](/filings/0001193125-25-267020.md) | [76.3](/filings/0001193125-26-197175.md) | [74.7](/filings/0001727263-26-000014.md) | [74.4](/filings/0001193125-25-267020.md) | [72.2](/filings/0001193125-26-197175.md) | [71.1](/filings/0001727263-26-000014.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 68,893,316 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001727263-26-000014.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.